MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation P/S Ratio 2011-2026 | NVTA
Annual P/S Ratio Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.18 | 18.8 | 23.8 | 8.2 | 6.33 | 4.77 | 11 | 23.6 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23.8 | 4.18 | 12.6 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
1.07 | $ 8.98 | 1.18 % | $ 598 M |  USA |
 |
Brainsway Ltd.
BWAY
|
8.09 | $ 13.87 | 1.61 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
2.14 | $ 26.0 | 0.64 % | $ 722 M | USA |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
5.47 | $ 68.09 | 2.64 % | $ 26.6 B | USA |
 |
Guardant Health
GH
|
13.7 | $ 88.7 | 1.74 % | $ 11.1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 155.4 | 2.26 % | $ 7.7 B | USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 17.57 | 1.44 % | $ 936 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 101.48 | 3.96 % | $ 8.37 B |  Irlanda |
 |
IQVIA Holdings
IQV
|
1.74 | $ 169.45 | 2.77 % | $ 29.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | $ 103.94 | 0.08 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 15.65 | 4.65 % | $ 473 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
1.29 | $ 17.5 | 1.21 % | $ 2.27 B | USA |
 |
Anixa Biosciences
ANIX
|
0.718 | $ 2.88 | 1.23 % | $ 93.5 K | USA |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.37 | 2.85 % | $ 2.03 B | USA |
 |
Danaher Corporation
DHR
|
6.09 | $ 194.76 | 1.76 % | $ 139 B | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Pacific Biosciences of California
PACB
|
3.11 | $ 1.4 | 3.16 % | $ 420 M | USA |
 |
Illumina
ILMN
|
3.75 | $ 121.73 | 2.05 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 199.39 | 0.23 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
6.64 | $ 113.69 | 1.66 % | $ 34.6 B | USA |
 |
BioNano Genomics
BNGO
|
0.115 | $ 1.12 | 0.9 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
2.13 | $ 9.28 | 10.24 % | $ 263 M | Israel |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 78.71 | 0.26 % | $ 5.31 B | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
5.13 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 457.78 | 0.91 % | $ 13.2 B | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
7.06 | $ 1 218.18 | 1.62 % | $ 25.1 B |  Schweiz |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Twist Bioscience Corporation
TWST
|
4.15 | $ 46.28 | 2.82 % | $ 2.77 B | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 18.07 | 3.85 % | $ 404 M | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 8.41 | 2.06 % | $ 1.08 B | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
6.47 | $ 201.38 | 1.87 % | $ 19.8 B | USA |